News Conference News ESC 2021 Fixed-Dose Combo Therapy Slashes CVD Risk in Primary Prevention Michael O'Riordan August 31, 2021
News Conference News ESC 2021 PRONOUNCE: No Difference in CVD Risks With Degarelix and Leuprolide for Prostate Cancer Michael O'Riordan August 30, 2021
News Opinion Editor's Corner ESC 2021 ESC 2021: Trials, Guidelines, and Channel Surfing at This Year’s Virtual Congress Shelley Wood August 19, 2021
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for July 2021 Shelley Wood August 02, 2021
News Daily News ARBs Preferable to ACE Inhibitors in Large Observational Hypertension Study Michael O'Riordan July 27, 2021
News Daily News Latest Statin Risk-Benefit Analysis: More Harm Than Good? Yael L. Maxwell July 15, 2021
News Daily News Hospital Stays for Meth-Related HF Skyrocket, as Do Costs Caitlin E. Cox July 14, 2021
News Daily News ASCVD Risk in South Asians Far Exceeds Forecasts by Common Scores Shelley Wood July 12, 2021
News Daily News FDA Approves Finerenone for Adults With CKD and Type 2 Diabetes Yael L. Maxwell July 09, 2021
News Daily News OMT Boosts Survival in Revascularized Patients at 10 Years Michael O'Riordan June 29, 2021
News Daily News Sleep Apnea Awareness, Treatment May Improve Some CVD Outcomes: AHA L.A. McKeown June 23, 2021
News Daily News Statins Not Linked to Dementia or Memory Changes: ASPREE Michael O'Riordan June 21, 2021
News Daily News Stopping Statins Ups CVD and Mortality Risks in Pill-Burdened Seniors Michael O'Riordan June 16, 2021
News Daily News COLCORONA: Mixed Results for Colchicine in Nonhospitalized COVID-19 Shelley Wood May 28, 2021
News Daily News US, European Agencies Looking Into Myocarditis Reports Tied to mRNA COVID-19 Vaccines Todd Neale May 24, 2021